Imidazolone → Imazapic
反応式
C1N=CNC1=O.[CH2:7]([C:9]1[CH:10]=[N:11][C:12]([C:18]2[NH:19][C:20](=[O:27])[C:21]([CH:24]([CH3:26])[CH3:25])([CH3:23])[N:22]=2)=[C:13]([CH:17]=1)[C:14]([OH:16])=[O:15])C.C(C1(CC(O)=O)C2C=CC=CC=2OCC1)(O)=O>>[CH:24]([C:21]1([CH3:23])[C:20](=[O:27])[NH:19][C:18]([C:12]2[N:11]=[CH:10][C:9]([CH3:7])=[CH:17][C:13]=2[C:14]([OH:16])=[O:15])=[N:22]1)([CH3:26])[CH3:25]参加物
4
実験手順
The composition according to claim 45 wherein the imidazolinone compound is 5-ethyl-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)nicotinic acid and the safener compound is selected from the group consisting of the diammonium salt of 4-carboxy-3,4-dihydro-2H-1-benzopyran-4-acetic acid and 4-carboxy-3,4-dihydro-2H-1-benzopyran-4-acetic acid.
出典と根拠
- ORDレコード
- ord-de7d3f2cb24c4ae282b0f211f38de673
- 出典データセット
- uspto-grants-1995_04
- DOI